secobarbital will lessen the level or effect of cannabidiol by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Monitor Carefully. Consider a rise in cannabidiol dosage (dependant on clinical reaction and tolerability) when coadministered with a robust CYP3A4 inducer.Right after binding acetylcholine, the AChR responds by an in